A Randomized Trial of Surgical Decision-Making Guided by TDTP-RECIST
Status:
NOT_YET_RECRUITING
Trial end date:
2028-12-31
Target enrollment:
Participant gender:
Summary
This project aims to conduct a prospective, multicenter, randomized controlled clinical trial. The study plans to enroll 270 patients with locally advanced iCCA who have successfully undergone GOLP conversion therapy. Participants will be randomized at a 1:2:2 ratio into three arms: Control Arm (continued medication), Direct Surgery Arm, and TDTP-RECIST Assessment Arm. The primary endpoint is Overall Survival (OS).
Phase:
NA
Details
Lead Sponsor:
Shanghai Zhongshan Hospital
Collaborators:
Oriental Hepatobiliary Surgery Hospital Affiliated to Naval Military Medical University Shanghai 10th People's Hospital Shanghai Geriatric Medical Center Shanghai Sixth People's Hospital, Shanghai Jiao Tong University School of Medicine